Tempest Therapeutics, Inc. Public Float
Tempest Therapeutics, Inc. (TPST) had Public Float of $30.10 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $30.10M.
- 2024-06-28: Entity Public Float $53.60M.
- 2023-06-30: Entity Public Float $16.00M.
- 2022-06-30: Entity Public Float $22.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $30.10M 10-K · filed 2026-03-30 |
| 2024-06-28 | $53.60M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $16.00M 10-K · filed 2024-03-19 |
| 2022-06-30 | $22.20M 10-K · filed 2023-03-22 |
| 2021-06-30 | $74.20M 10-K/A · filed 2022-04-01 |
| 2021-06-29 | $74.20M 10-K · filed 2022-03-29 |
| 2020-06-30 | $33.30M 10-K/A · filed 2021-04-29 |
| 2019-06-28 | $124.40M 10-K · filed 2020-03-11 |
| 2018-06-29 | $29.90M 10-K · filed 2019-04-01 |
| 2017-06-30 | $50.90M 10-K · filed 2018-03-15 |
| 2016-06-30 | $168.70M 10-K · filed 2017-03-02 |
| 2015-06-30 | $727.20M 10-K · filed 2016-02-26 |
| 2014-06-30 | $140.90M 10-K · filed 2015-03-16 |
| 2013-06-28 | $97.00M 10-K · filed 2014-02-27 |
| 2012-06-30 | $9.01M 10-K · filed 2013-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |